RUBIUS THERAPEUTICS INC (RUBY)
US78116T1034 - Common Stock
| 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 14.87M | 225.85M | 91.20M | 91.90M | 307.10M | |||
| Marketable Securities | N/A | 0.00 | 85.10M | 191.40M | 97.00M | |||
| Other Current Assets | 5.33M | 3.98M | 5.20M | 6.00M | 10.30M | |||
| Total Current Assets | 20.20M | 229.82M | 181.50M | 289.30M | 414.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.83M | 86.63M | 94.40M | 103.50M | 62.80M | |||
| Other Non-Current Assets | 50.00K | 1.57M | 1.90M | 2.10M | 1.90M | |||
| Total Non-Current Assets | 2.88M | 88.20M | 96.30M | 105.50M | 64.70M | |||
| TOTAL ASSETS | 23.07M | 318.02M | 277.80M | 394.80M | 479.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 4.50M | |||
| Accrued Expenses | 4.41M | 22.42M | 21.80M | 26.30M | 5.60M | |||
| Accounts Payable | 1.23M | 11.57M | 5.50M | 7.20M | 7.90M | |||
| Other Current Liabilities | 2.30M | 670.00K | 600.00K | 300.00K | 2.00M | |||
| Total Current Liabilities | 7.94M | 34.66M | 27.80M | 33.80M | 20.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 76.15M | 74.90M | 49.60M | 65.80M | |||
| Other Non-Current Liabilities | 0.00 | 28.43M | 33.50M | 37.30M | 300.00K | |||
| Total Non-Current Liabilities | 0.00 | 104.58M | 108.40M | 86.80M | 66.10M | |||
| TOTAL LIABILITIES | 7.94M | 139.24M | 136.20M | 120.60M | 86.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -856.68M | -677.02M | -480.50M | -312.70M | -150.10M | |||
| Additional Paid In Capital | 871.73M | 855.71M | 621.90M | 586.80M | 543.00M | |||
| Common Shares | 90.00K | 90.00K | 100.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | N/A | 0.00 | 0.00 | 100.00K | 0.00 | |||
| Shares Outstanding | 90.39M | 90.06M | 81.10M | 80.00M | 79.20M | |||
| Tangible Book Value per Share | 0.17 | 1.99 | 1.75 | 3.43 | 4.96 | |||
| Total Shareholders' Equity | 15.13M | 178.78M | 141.60M | 274.20M | 393.00M | |||
| TOTAL LIABILITIES AND EQUITY | 23.07M | 318.02M | 277.80M | 394.80M | 479.10M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.43 | 0.53 | 0.18 | 0.17 | |||
| Current Ratio | 2.54 | 6.63 | 6.53 | 8.56 | 20.72 | |||
| Return On Assets (ROA) | -778.79% | -61.80% | -60.38% | -41.40% | -18.62% | |||
| Return On Equity (ROE) | -1187.40% | -109.94% | -118.45% | -59.61% | -22.70% | |||
All data in USD